0001447362-20-000175.txt : 20200814
0001447362-20-000175.hdr.sgml : 20200814
20200814160957
ACCESSION NUMBER: 0001447362-20-000175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200812
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAETZOLD DEREK J
CENTRAL INDEX KEY: 0001239501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 201105141
MAIL ADDRESS:
STREET 1: 820 S. FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wf-form4_159743570029800.xml
FORM 4
X0306
4
2020-08-12
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001239501
MAETZOLD DEREK J
C/O CASTLE BIOSCIENCES, INC.
820 S. FRIENDSWOOD DRIVE, SUITE 201
FRIENDSWOOD
TX
77546
1
1
0
0
Pres. & Chief Exec. Officer
Common Stock
2020-08-12
4
S
0
800
40.297
D
1563048
D
Common Stock
2020-08-12
4
S
0
4200
41.903
D
1558848
D
Common Stock
2020-08-13
4
S
0
7300
40.973
D
1551548
D
Common Stock
2020-08-13
4
S
0
200
41.70
D
1551348
D
Common Stock
2020-08-13
4
S
0
1000
40.909
D
1550348
D
Common Stock
159329
I
By trust
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020.
This transaction was executed in multiple trades at prices ranging from $39.940 to $40.765, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $41.520 to $42.240, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 18, 2020.
This transaction was executed in multiple trades at prices ranging from $40.670 to $41.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $40.690 to $41.110, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by the DJM Grantor Retained Annuity Trust No. 1, or the Maetzold Trust. The Reporting Person is a trustee of the Maetzold Trust.
/s/ Greg Acosta, Attorney-in-fact
2020-08-14